ArticleFundamental research2026
Geometric deep learning-enabled metal-binding site identification and grafting.
Article in Fundamental research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metal-binding sites can participate in enzymes' catalytic reactions, as well as in protein folding, stability, and protein-protein interactions. In-depth research on metal-binding sites can aid in identifying new protein functions and designing new metalloproteins. We present MeSiteIG, a geometric deep learning-driven bifunctional tool with capabilities for both Metal-binding Site Identification and Grafting, established based on the geometric conservation of metal-binding sites. It comprises three main modules: residue triplet searcher (ResTriS), metal-binding site identifier (MeSI), and metal-binding site alignment (MeSA). As the core module, MeSI adopts E3-equivarient graph neural networks to predict potential metal-binding site residues, without the coordinating residue types and side-chain information. MeSI achieved superior performance on the independent test set, with an impressive speed of approximately 300 samples per second. Using MeSiteIG, we identified previously neglected protein metal-binding sites and potential protein bimetallic sites. Furthermore, it could graft metal sites onto antibody surfaces and protein pockets, creating new potentially valuable metalloproteins.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.